Nasopharyngeal carcinoma: alternative treatment options after disease progression

Endoscopic nasopharyngectomy with potassium-titanyl-phosphate (KTP) laser for early locally recurrent nasopharyngeal carcinoma

(2009) Jenq-Yuh Ko et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

(2009) Robert Pirker et al.   LANCET

Endoscopic nasopharyngectomy for locally recurrent nasopharyngeal carcinoma

(2009) Ming-Yuan Chen et al.   LARYNGOSCOPE

Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

(2009) Eric Van Cutsem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma

(2008) Swan Swan Leong et al.   CANCER

Age-Incidence Curves of Nasopharyngeal Carcinoma Worldwide: Bimodality in Low-Risk Populations and Aetiologic Implications

(2008) F. Bray et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma

(2008) Daniel T. T. Chua et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Capecitabine Monotherapy for Recurrent and Metastatic Nasopharyngeal Cancer

(2008) D. Chua et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY